Beyond the Obvious: Metrics That Matter for Early-Commercial HealthTech Companies

Bring your morning coffee and come learn about scale-up metrics you should be tracking to demonstrate traction.

​Brought to you by OBIO® and MaRS, if you're gearing up to grow from early revenue $1M to $10M+, this workshop breaks down the commercial and non-obvious scale-up metrics investors look for when assessing companies transitioning into early revenue generating business. Learn how to forecast, measure, and present the numbers that actually drive VC conviction and funding, with MaRS capital advisor Billy Lai.

​Due to the limited space of the venue, all registered attendees must be approved and priority goes to Health Tech companies participating in our competitive accelerator programs and in early revenue. This is an in-person event only.

To learn more or to register, please write to Jack Lee.